Idiopathic short stature in the genomic era: a focused narrative review of genotype-phenotype correlation, selective neuroimaging, IGF-1 biology, and growth hormone responsiveness
Ashraf Soliman, Fawzia Alyafei, Ahmed Elawwa, Nada Alaaraj, Noor Hamed, Shayma Mohamed · 2026
Read Idiopathic short stature in the genomic era: a focused narrative review of genotype-phenotype correlation, selective neuroimaging, IGF-1 biology, and growth hormone responsiveness by Ashraf Soliman, Fawzia Alyafei, Ahmed Elawwa, Nada Alaaraj, Noor Hamed, Shayma Mohamed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13630432.txt.
Description
Ashraf Soliman and five colleagues review unexplained short stature in the genomic era. Their study appeared in 2026. The label covers short children whose standard workup finds no cause. The authors argue it should be a working label, not a final diagnosis. Modern testing keeps moving these children into defined genetic disorders.
Test yield climbs steeply with test power. It runs from single-gene checks through chromosome arrays and panels to full exome sequencing. The strongest route solves roughly a third of cases. Recurring culprits include genes shaping the growth plate and the growth hormone path. Brain imaging findings are usually unhelpful. Growth hormone response depends on the gene fault. Some defects respond robustly and others modestly. Careful trait mapping anchors their advice. So does honest handling of unclear variants.
Catalog record
| CREATOR | Ashraf Soliman, Fawzia Alyafei, Ahmed Elawwa, Nada Alaaraj, Noor Hamed, Shayma Mohamed |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38109 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |